The inhibition of tumor progression by Trunc‐LMP2A‐RNP and FL‐LMP2A‐RNP was significantly more potent than that in the irrelevant‐RNP group (Figure S7B, Supporting Information). This evidence concerns the gene RNPC3 and neoplasm.